Abstract
Purpose: To quantitatively investigate the feasibility of MRI as a tool for assessing the spatial distribution of a convectively delivered agent using a canine prostate model. Materials and Methods: Canine prostates (ex vivo, n = 3; in vivo, n = 12) were injected under several injection paradigms with a solution of gadolinium-DTPA for MR contrast and methylene blue as a grossly visible surrogate drug marker. Ex vivo and in vivo distributions were assessed at 1.5T and quantitatively compared. Results: Measured distributions using MRI and methylene blue pathology photographs were analyzed using a Bland-Altman method. The fractional percentage volume covered (Vfrac) compared the measurements grossly: Pearson's correlation coefficients were R = 0.99 for ex vivo and R = 0.77 for in vivo (P < 0.05). The fractional percentage of area covered (Afrac) demonstrated the high degree of spatial correlation between individual slices: R = 0.93 for ex vivo and R = 0.98 for in vivo (P < 0.05). There was no statistically observable bias in scale or offset between the measurements. Conclusion: Measured distributions using MRI and pathology were highly correlated and unbiased, indicating the potential of MRI as a tool for quantitative assessment of interstitial delivery of injected therapies in vivo.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1672-1677 |
| Number of pages | 6 |
| Journal | Journal of Magnetic Resonance Imaging |
| Volume | 26 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2007 |
Keywords
- Animal model
- Convective therapy
- Imaging-guided therapy
- Magnetic resonance imaging
- Prostate
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
MD Anderson CCSG core facilities
- Small Animal Imaging Facility
Fingerprint
Dive into the research topics of 'Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS